These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12456230)

  • 21. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis.
    Liang PS; Mayer JD; Wakefield J; Trinh-Shevrin C; Kwon SC; Sherman SE; Ko CW
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00155. PubMed ID: 32352722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance.
    Cokkinides V; Bandi P; Shah M; Virgo K; Ward E
    BMC Health Serv Res; 2011 Jan; 11():19. PubMed ID: 21272321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan.
    Wharam JF; Graves AJ; Landon BE; Zhang F; Soumerai SB; Ross-Degnan D
    Med Care; 2011 Sep; 49(9):865-71. PubMed ID: 21577162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.
    White A; Vernon SW; Franzini L; Du XL
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):811-7. PubMed ID: 21546366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
    Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
    Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer screening, 1997-1999: role of income, insurance and policy.
    Adams EK; Thorpe KE; Becker ER; Joski PJ; Flome J
    Prev Med; 2004 May; 38(5):551-7. PubMed ID: 15066357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005.
    Doubeni CA; Laiyemo AO; Reed G; Field TS; Fletcher RH
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2170-5. PubMed ID: 19622721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal testing utilization and payments in a large cohort of commercially insured US adults.
    Ladabaum U; Levin Z; Mannalithara A; Brill JV; Bundorf MK
    Am J Gastroenterol; 2014 Oct; 109(10):1513-25. PubMed ID: 24980877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
    Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
    Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sociodemographic Factors and Screening CT Colonography Use Among Medicare Beneficiaries.
    Christensen EW; Sanelli PC; Rula EY; Chang KJ; Moreno CC; Bruining DH; Yee J
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329703. PubMed ID: 37466190
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
    Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA
    Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial disparities and trends in use of colorectal procedures among Tennessee elderly (1996-2000).
    Zhao BB; Kilbourne B; Stain SC; Van Cain A; Briggs NC; Husaini BA; Levine R
    Ethn Dis; 2006; 16(2):412-20. PubMed ID: 17682243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of colorectal cancer testing using the California Health Inventory Survey.
    Modiri A; Makipour K; Gomez J; Friedenberg F
    World J Gastroenterol; 2013 Feb; 19(8):1247-55. PubMed ID: 23482920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Contributing to Delay in Specialist Care After Colorectal Cancer Diagnosis in Kentucky.
    Chow Z; Osterhaus P; Huang B; Chen Q; Schoenberg N; Dignan M; Evers BM; Bhakta A
    J Surg Res; 2021 Mar; 259():420-430. PubMed ID: 33092860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries.
    Cooper GS; Doug Kou T
    Cancer; 2008 Jan; 112(2):293-9. PubMed ID: 18072273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening.
    Harewood GC; Lieberman DA
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):72-7. PubMed ID: 15017635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.